Sort by:

Type
Topic

First in the Industry to use Revolutionary Dry Ice Shipping Solution for APIs that Require Below -70°C

We are proud to be the first API manufacturer to partner with Envirotainer AB, introducing their revolutionary -70°C dry ice shipping solution, CryoSure®, to our customers. This innovative technology is currently the only one of its kind on the market , enabling both local and global access to safe distribution of pharmaceuticals and patient samples.

R&D

Working Hand in Hand With Our Customers: API Development Through the Eyes of the Formulator

At Teva api R&D, we work extremely closely with our customers to develop drug substances that best fit their formulation needs.   In generic API development, we identify the most likely formulation and focus on potential critical attributes in the API that may impact the formulation process and properties. When providing CDMO services, our focus is […]

ESG Articles

Teva Receives Highest Ever 2024 EcoVadis Score

Teva has been awarded a 2024 EcoVadis score of 73/100, in recognition of our sustainability efforts. This score is even higher than last year, placing us in the top 4% of all pharmaceutical companies rated by EcoVadis. Receiving such a high score is not only a huge honor for Teva and Teva api, but also […]

Meet the Expert Articles

Meet the Expert – Yonathan Tobis, Product Manager

Product Manager, Yonathan Tobis, is responsible for 50+ commercial and pipeline products in Teva api’s portfolio. See what being a product manager is all about, which skills are most valuable, and what Yonathan finds most satisfying about the role. I’m an industrial engineer by profession. I first worked as a project controller for a homeland […]

Industry updates Articles

Harnessing the Power of AI and Machine Learning to Revolutionize API Production

The Teva API site in Santhià, Italy, embarked on an innovative project to use artificial intelligence (AI) and machine learning (ML) to revolutionize API production. The aim was to optimize and standardize the production process to reduce variability, raw material usage, and energy consumption, while enhancing productivity and API purity. It also sought to minimize […]

R&D Articles

The Art of API Sterilization: A Teva API Niche

API sterilization is a very niche market. But when it’s needed, it must be done right. Sterilization a crucialis a crucial step in the manufacturing of certain drug products and is key to ensuring patient safety.  Over the last few years, Teva API has been developing a state-of-the-art sterilization facility in Croatia that was built […]

Meet the Expert Articles
green chemistry

Green Chemistry at Teva api – Our R&D team’s initiative to making an environmental impact

Last year, Teva api’s R&D leadership team got together to brainstorm about what could be done on a departmental level to make a substantial environmental impact. As a result of this meeting, a new “community” was formed called the R&D Green Community, and over the last year it has established many initiatives.   The mission of […]

Meet the Expert Articles
Andrea Szilagyi

Women, Science, and Leadership—an Interview with Andrea Szilagyi

11 February is the International Day of Women and Girls in Science. At Teva api, women make up a large percentage of the work force and leadership positions in our R&D and manufacturing teams across the globe. Today, Andrea Szilagyi, Associate Director of R&D at our Debrecen, Hungary site, tells us what inspired her to […]

Regulatory Affairs Webinars
Global API Regulation

WEBINAR: Global API Regulation in 2023: What it Means for You

We recently held a webinar on the topic of changes and updates to global API regulation in 2023. Teva api regulatory experts from across 5 different markets – US, EU, LATAM, Japan & China, came together to talk about what’s new in each market, and to share their insights about what to be looking out […]

ESG Articles
Securing Supply in Europe

Securing Supply in Europe – where does Teva api fit it?

During COVID-19, the shortage of basic drugs in key EU countries led to growing calls to push local drug manufacturing to ensure a smooth supply and to minimize shortages. Following the pandemic, the war in Ukraine, and the Russian gas supply issue, several countries have called for bringing back pharma production (including finished dosages and […]

Last site inspections

Aug 5, 2024
Teva API had a successful inspection in the Teva api Czech, Opava site by SÚKL (State institute of drug control)
Mar 15, 2024
Teva API had a successful inspection in the Teva api India, Gajraula site by Local MOH
Jan 2, 2024
Teva API had a successful inspection in the Teva api Hungary site by ANVISA
View all Site Inspections

Last regulatory updates

Feb 15, 2024
CADIFA
Feb 15, 2024
US DMF
Jan 15, 2024
US DMF
View all Regulatory Updates